Clinical Report: Ongoing Glucose Monitoring in Individuals With and Without Diabetes

Overview

Continuous glucose monitors (CGMs) are increasingly used by individuals with and without diabetes to track blood glucose levels. While CGMs can assist in insulin management for those with diabetes, evidence supporting their use in non-diabetic populations remains limited according to recent studies.

Background

The use of CGMs has become common among individuals with diabetes, particularly for those on insulin therapy, as they provide real-time glucose data that can inform treatment decisions. However, their application in non-diabetic individuals raises questions about the benefits and potential drawbacks, including the risk of unnecessary dietary restrictions and stress from constant monitoring, as noted in recent literature.

Data Highlights

Recent studies indicate that CGM use in diabetic populations can lead to improved glycemic control. However, the impact of CGMs on non-diabetic individuals remains unclear, with some studies suggesting potential psychological effects and dietary changes that may not be beneficial.

Key Findings

• CGMs provide continuous glucose data, which can assist in insulin dose adjustments for individuals with diabetes.

• There is insufficient evidence that CGM use prevents complications or severe hypoglycemic reactions in diabetic patients compared to usual care.

• In non-diabetic individuals, the health benefits of CGM use are not well established, and concerns exist regarding potential over-restriction of healthy foods.

• CGMs may cause skin irritation and can malfunction, leading to interruptions in monitoring.

• For insulin-treated individuals, CGMs may reduce the need for finger-stick testing, improving comfort and management.

Clinical Implications

Healthcare providers should consider the individual needs of patients when recommending CGMs, particularly for those with diabetes. For non-diabetic individuals, the potential psychological and behavioral impacts of CGM use warrant careful discussion, as highlighted in recent studies.

Conclusion

While CGMs can enhance diabetes management for some patients, their role in non-diabetic populations remains uncertain and requires further investigation, as indicated by current research.

Related Resources & Content

1. American Diabetes Association, Diabetes Care, 2026 -- Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes

2. American Diabetes Association, Diabetes Care, 2026 -- Diabetes Technology: Standards of Care in Diabetes

3. JAMA Network Open, 2023 -- Primary Care–Initiated Continuous Glucose Monitoring in Adults With Insulin-Treated Diabetes

4. JAMA Network Open, 2023 -- Implementing Continuous Glucose Monitoring Alerts in Clinical Settings—Moving Beyond Efficacy

5. European Journal of Medical Research, 2026 -- Continuous glucose monitoring in non-diabetic populations: a systematic review of observational and interventional studies with meta-analysis

6. Ophthalmology Management — Diabetes

7. MDSpire News — CGM in Early Gestational Diabetes Improved Outcomes

8. 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes—2026 | Diabetes Care | American Diabetes Association

9. 7. Diabetes Technology: Standards of Care in Diabetes—2026 | Diabetes Care | American Diabetes Association

10. Continuous glucose monitoring in non-diabetic populations: a systematic review of observational and interventional studies with meta-analysis | European Journal of Medical Research | Springer Nature Link